Logo.png
Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
September 29, 2022 17:00 ET | Imunon, Inc.
LAWRENCEVILLE, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company focused on DNA-based immunotherapy and next-generation vaccines, today...